RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.

Metastasis accounts for the most deaths in patients with hepatocellular carcinoma (HCC). Receptor activator of nuclear factor kappa B ligand (RANKL) is associated with cancer metastasis, while its role in HCC remains largely unknown.Immunohistochemistry was performed to determine the expression of R...

Full description

Bibliographic Details
Main Authors: Fang-Nan Song, Meng Duan, Long-Zi Liu, Zhi-Chao Wang, Jie-Yi Shi, Liu-Xiao Yang, Jian Zhou, Jia Fan, Qiang Gao, Xiao-Ying Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4182493?pdf=render
_version_ 1818612389445107712
author Fang-Nan Song
Meng Duan
Long-Zi Liu
Zhi-Chao Wang
Jie-Yi Shi
Liu-Xiao Yang
Jian Zhou
Jia Fan
Qiang Gao
Xiao-Ying Wang
author_facet Fang-Nan Song
Meng Duan
Long-Zi Liu
Zhi-Chao Wang
Jie-Yi Shi
Liu-Xiao Yang
Jian Zhou
Jia Fan
Qiang Gao
Xiao-Ying Wang
author_sort Fang-Nan Song
collection DOAJ
description Metastasis accounts for the most deaths in patients with hepatocellular carcinoma (HCC). Receptor activator of nuclear factor kappa B ligand (RANKL) is associated with cancer metastasis, while its role in HCC remains largely unknown.Immunohistochemistry was performed to determine the expression of RANK in HCC tissue (n = 398). Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were used to examine the expression of RANK, E-cadherin, N-cadherin, vimentin, Snail, Slug, Twist and MMPs in HCC cells. Wound healing and Transwell assays were used to evaluate cell migration and invasion ability.We found that expression of RANK, the receptor of RANKL, was significantly higher in HCC tumor tissues than in peritumor liver tissues (p<0.001). Constitutive expression of RANK was detected in HCC cell lines, which can be up-regulated when HCC cells were stimulated with RANKL. Notably, in vitro experiments showed that activation of RANKL-RANK axis significantly promoted migration and invasion ability of HCC cells. In addition, RANKL stimulation increased the expression levels of N-cadherin, Snail, and Twist, while decreased the expression of E-cadherin, with concomitant activation of NF-κB signaling pathway. Moreover, administration of the NF-κB inhibitor attenuated RANKL-induced migration, invasion and epithelial-mesenchymal transition of HCC cells.RANKL could potentiate migration and invasion ability of RANK-positive HCC cells through NF-κB pathway-mediated epithelial-mesenchymal transition, which means that RANKL-RANK axis could be a potential target for HCC therapy.
first_indexed 2024-12-16T15:45:27Z
format Article
id doaj.art-fb22b85191044f309ce9b3eb2fa0fc3d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-16T15:45:27Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-fb22b85191044f309ce9b3eb2fa0fc3d2022-12-21T22:25:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10850710.1371/journal.pone.0108507RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.Fang-Nan SongMeng DuanLong-Zi LiuZhi-Chao WangJie-Yi ShiLiu-Xiao YangJian ZhouJia FanQiang GaoXiao-Ying WangMetastasis accounts for the most deaths in patients with hepatocellular carcinoma (HCC). Receptor activator of nuclear factor kappa B ligand (RANKL) is associated with cancer metastasis, while its role in HCC remains largely unknown.Immunohistochemistry was performed to determine the expression of RANK in HCC tissue (n = 398). Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot were used to examine the expression of RANK, E-cadherin, N-cadherin, vimentin, Snail, Slug, Twist and MMPs in HCC cells. Wound healing and Transwell assays were used to evaluate cell migration and invasion ability.We found that expression of RANK, the receptor of RANKL, was significantly higher in HCC tumor tissues than in peritumor liver tissues (p<0.001). Constitutive expression of RANK was detected in HCC cell lines, which can be up-regulated when HCC cells were stimulated with RANKL. Notably, in vitro experiments showed that activation of RANKL-RANK axis significantly promoted migration and invasion ability of HCC cells. In addition, RANKL stimulation increased the expression levels of N-cadherin, Snail, and Twist, while decreased the expression of E-cadherin, with concomitant activation of NF-κB signaling pathway. Moreover, administration of the NF-κB inhibitor attenuated RANKL-induced migration, invasion and epithelial-mesenchymal transition of HCC cells.RANKL could potentiate migration and invasion ability of RANK-positive HCC cells through NF-κB pathway-mediated epithelial-mesenchymal transition, which means that RANKL-RANK axis could be a potential target for HCC therapy.http://europepmc.org/articles/PMC4182493?pdf=render
spellingShingle Fang-Nan Song
Meng Duan
Long-Zi Liu
Zhi-Chao Wang
Jie-Yi Shi
Liu-Xiao Yang
Jian Zhou
Jia Fan
Qiang Gao
Xiao-Ying Wang
RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
PLoS ONE
title RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
title_full RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
title_fullStr RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
title_full_unstemmed RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
title_short RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
title_sort rankl promotes migration and invasion of hepatocellular carcinoma cells via nf κb mediated epithelial mesenchymal transition
url http://europepmc.org/articles/PMC4182493?pdf=render
work_keys_str_mv AT fangnansong ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition
AT mengduan ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition
AT longziliu ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition
AT zhichaowang ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition
AT jieyishi ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition
AT liuxiaoyang ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition
AT jianzhou ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition
AT jiafan ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition
AT qianggao ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition
AT xiaoyingwang ranklpromotesmigrationandinvasionofhepatocellularcarcinomacellsvianfkbmediatedepithelialmesenchymaltransition